Jeffrey N. Hausfeld

BioFactura, Inc. develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs. It also specializes in developing and performing in-process and release analytical assays including HPLC methods, SDS-PAGE and Western analysis, antibody/antigen capture ELISAs, and bioactivity methods. The company was founded by Darryl Sampey and Alexandre DeSeabra in 2004 and is headquartered in Frederick, MD.

Virginia Innovation Partnership Corporation (Virginia Innovation Partnership) is a private equity/venture capital non-profit operating division of the Virginia Innovation Partnership Authority firm founded in 1985. The firm is headquartered in Herndon, Virginia.

NexGen Medical Systems, Inc. develops medical devices that enhance the safety and effectiveness of interventional procedures in patients with debilitating neurological and cardiovascular diseases. The firm focuses on commercializing an integrated medical device product line for removal of blood clots from head, neck, and peripheral vessels. The company was founded by Richard E. Latchaw, John Kucharczyk and George T. Gillies and is headquartered in Wayzata, MN.